Open AccessIncident AIDS or death after initiation of human immunodeficiency virus treatment regimens including raltegravir or efavirenz among adults in the United States
Author(s) -
S.R. Cole,
J.K. Edwards,
H.I. Hall,
M.A. Brookhart,
W.C. Mathews,
R.D. Moore,
H.M. Crane,
M.M. Kitahata,
M.J. Mugavero,
M.S. Saag,
J.J. Eron,
Centers for AIDS Research Network of Integrated Clinical Systems Investigators
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ef49-8521
Subject(s) - raltegravir , efavirenz , human immunodeficiency virus (hiv) , medicine , virology , integrase inhibitor , antiretroviral therapy , viral load